Collectively, our findings may suggest new mechanistic insights into the dysfunction induced by exposure to HIV-Tat protein and opioids, while demonstrating that DMF might benefit HIV-1 and opioid use disorder patients. This evidence concerns the gene TAT and opioid use disorder.